Luke studied Biomedical Science for his undergraduate degree at the University of West of England (2007) before going on to work in the testing laboratories at the NHS Blood and Transplant. He then went on to work for the pharmaceutical company Vectura for over 5 years before embarking on a PhD under the supervision of Dr. Robin Curtis at the University of Manchester. Here he studied the effects of denaturants on aggregation propensity of biopharmaceuticals and forms the basis of this talk. Luke now works for Wyatt Technology in the UK as a Field Application Scientist and has done so for the last 3 years.